Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Berberine, RXRα/PPARγ, and SASP in Atherosclerosis
2026-08-27
A 2025 study identifies an RXRα/PPARγ/NEDD4 signaling axis through which berberine suppresses SASP-related inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse pathology, foam-cell assays, Smart-seq analysis, and macrophage-targeted RXRα knockdown provides a mechanistic framework for connecting nuclear-receptor activity with ubiquitin-dependent clearance of a GATA4/p62 complex.
-
Stat3 in Fyn-Driven Dopaminergic Neurodegeneration
2026-08-27
This 2024 zebrafish study identifies Stat3 as a downstream effector linking constitutively active Fyn signaling to dopaminergic neuron loss and microglial inflammation. Its combination of neural-specific genetic activation, live imaging, transcriptomics, and pathway inhibition provides a mechanistic framework for Parkinson’s disease-related functional gene studies.
-
Ferroptosis Inducers in Advanced Prostate Cancer
2026-08-26
Ghoochani and colleagues show that treatment-resistant prostate cancer models retain expression of key ferroptosis regulators and respond to erastin or RSL3, a glutathione peroxidase 4 inhibitor. Their preclinical data support ferroptosis induction, alone or combined with second-generation anti-androgens, as a strategy for limiting prostate cancer cell growth, migration, and tumor progression.
-
Heparin sodium for Coagulation Research
2026-08-26
Heparin sodium provides a practical control point for anti-factor Xa activity assays, aPTT measurement, and translational thrombosis workflows. This guide also shows how to use coagulation controls when studying plant-derived nanovesicles, without overstating an unvalidated connection between heparin and Sertoli-cell delivery.
-
Direct Mouse Genotyping Kit: PCR Workflow
2026-08-25
The Direct Mouse Genotyping Kit supports genomic DNA release and direct PCR amplification from mouse tissue without conventional purification, simplifying routine mouse genetic screening and high-throughput genotyping. It is intended for PCR-based assays, not applications requiring highly purified DNA or unvalidated downstream enzymatic workflows.
-
WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis
2026-08-25
This study identifies the WNT5a/GSK3/β-catenin axis as a key regulator of adipogenic differentiation in skeletal-muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological screening, mass cytometry, transcriptomics, and in vivo muscle-injury models, the authors show that GSK3 inhibition suppresses fat formation while enhancing FAP support of muscle satellite-cell differentiation.
-
Chlorin e6 Workflows for PDT Research
2026-08-24
Chlorin e6 supports controllable ROS-based experiments spanning anticancer photodynamic therapy and antibacterial wound scaffolds. This guide translates the Ce6 photosensitizer into practical formulation, irradiation, assay, and troubleshooting workflows, including the aligned silk-fibroin platform reported for infected wound healing.
-
Methoxy-X04 Workflows for Amyloid Imaging
2026-08-24
Methoxy-X04 converts amyloid pathology into a practical fluorescent readout for plaque mapping, cerebrovascular amyloid visualization, and treatment-response studies. Its brain permeability and affinity for fibrillary Aβ make it especially useful for connecting rTMS-driven microglial clearance with measurable changes in Alzheimer’s disease models.
-
Phosbind Biotin LC Western Blot Guide
2026-08-23
Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes. It is suited to Western Blot workflows using streptavidin-HRP and chemiluminescence, but not to aqueous-only protocols or long-term storage of working solutions.
-
Morin: Mechanism, Evidence, and Research Workflow
2026-08-22
Morin is a natural flavonoid with the systematic name 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one. Its research value combines antioxidant and inflammation-related pathway studies, reported inhibition of adenosine 5′-monophosphate deaminase, and fluorescent metal-ion detection.
-
Methoxy-X04 Reveals Exercise-Linked Aβ Clearance
2026-08-21
Methoxy-X04 is a brain-permeable fluorescent amyloid beta probe for mapping plaques, oligomers, and cerebrovascular deposits in Alzheimer’s disease models. This article connects its assay logic to new evidence that muscle-derived extracellular vesicles enhance microglial amyloid clearance after exercise.
-
Allosteric PDK4 Inhibitors for Metabolic Disease
2026-08-20
Jeon and colleagues developed an anthraquinone-derived series of allosteric pyruvate dehydrogenase kinase 4 inhibitors and identified compound 8c as a potent biochemical lead. The study connects PDK4 inhibition with improved glucose tolerance, reduced allergic responses, and anticancer activity in preclinical models while highlighting metabolic stability, pharmacokinetics, and docking as key development considerations.
-
Exercise, EVs, and Amyloid Clearance in AD Mice
2026-08-20
A 2026 Nature Aging study identifies skeletal muscle-derived extracellular vesicles as a mediator of exercise-related cognitive benefit in Alzheimer’s disease mice. The work connects swimming exercise, miR-378a-3p cargo, disease-associated microglia, lipid metabolism, and amyloid-beta plaque clearance, suggesting a mechanistically defined exercise-mimicking strategy.
-
AMPK–SQSTM1 Feedback Under Metabolic Stress
2026-08-19
A 2024 Autophagy study identifies a double-positive feedback loop between AMPK and SQSTM1/p62 that couples energy-stress adaptation to NRF2-dependent antioxidant defense. The work clarifies how lysosomal signaling, p62 phosphorylation, and metabolic context may help explain adaptation in STK11/LKB1- and KEAP1-altered lung cancer.
-
JSH-23: Mechanism and NF-κB Inhibition
2026-08-19
JSH-23 is a small-molecule NF-κB inhibitor that suppresses p65 nuclear localization and DNA binding without blocking IκB degradation. Evidence from macrophage, airway epithelial, and cisplatin-induced acute kidney injury model studies supports its use as a mechanistic research tool, while also showing that pathway dependence varies by biological context.